181 related articles for article (PubMed ID: 36271235)
1. Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy.
Testa F; Melillo P; Di Iorio V; Iovino C; Farinaro F; Karali M; Banfi S; Rossi S; Della Corte M; Simonelli F
Sci Rep; 2022 Oct; 12(1):17637. PubMed ID: 36271235
[TBL] [Abstract][Full Text] [Related]
2. Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting.
Lorenz B; Künzel SH; Preising MN; Scholz JP; Chang P; Holz FG; Herrmann P
Ophthalmology; 2024 Feb; 131(2):161-178. PubMed ID: 37704110
[TBL] [Abstract][Full Text] [Related]
3. Morphologic characteristics of the outer retina in cone dystrophy on spectral-domain optical coherence tomography.
Cho SC; Woo SJ; Park KH; Hwang JM
Korean J Ophthalmol; 2013 Feb; 27(1):19-27. PubMed ID: 23372375
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography automated layer segmentation of macula after retinal detachment repair.
Han KJ; Lee YH
PLoS One; 2018; 13(5):e0197058. PubMed ID: 29734400
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the visual prognoses of branch retinal artery obstruction and foveal thickness on OCT.
Cho HJ; Kim CG; Kim JW; Lee JH
Korean J Ophthalmol; 2010 Oct; 24(5):297-301. PubMed ID: 21052510
[TBL] [Abstract][Full Text] [Related]
6. Natural history and biomarkers of retinal dystrophy caused by the biallelic TULP1 variant c.148delG.
Majander A; Sankila EM; Falck A; Vasara LK; Seitsonen S; Kulmala M; Haavisto AK; Avela K; Turunen JA
Acta Ophthalmol; 2023 Mar; 101(2):215-221. PubMed ID: 36128853
[TBL] [Abstract][Full Text] [Related]
7. Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis.
Gange WS; Sisk RA; Besirli CG; Lee TC; Havunjian M; Schwartz H; Borchert M; Sengillo JD; Mendoza C; Berrocal AM; Nagiel A
Ophthalmol Retina; 2022 Jan; 6(1):58-64. PubMed ID: 33838313
[TBL] [Abstract][Full Text] [Related]
8. Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice.
Melillo P; Testa F; Di Iorio V; Karali M; Citro A; Della Corte M; Rossi S; Banfi S; Simonelli F
Ophthalmol Retina; 2024 Jul; 8(7):688-698. PubMed ID: 38295874
[TBL] [Abstract][Full Text] [Related]
9. Visual Acuity, Retinal Morphology, and Patients' Perceptions after Voretigene Neparovec-rzyl Therapy for RPE65-Associated Retinal Disease.
Sengillo JD; Gregori NZ; Sisk RA; Weng CY; Berrocal AM; Davis JL; Mendoza-Santiesteban CE; Zheng DD; Feuer WJ; Lam BL
Ophthalmol Retina; 2022 Apr; 6(4):273-283. PubMed ID: 34896323
[TBL] [Abstract][Full Text] [Related]
10. Foveal Morphology of Normal Fellow Eyes of Patients with Unilateral Macular Hole.
Kumagai K; Ogino N; Horie E; Fukami M; Furukawa M
Ophthalmol Retina; 2022 May; 6(5):361-368. PubMed ID: 34999016
[TBL] [Abstract][Full Text] [Related]
11. Short term morphological rescue of the fovea after gene therapy with voretigene neparvovec.
Kortüm FC; Kempf M; Jung R; Kohl S; Ott S; Kortuem C; Sting K; Stingl K
Acta Ophthalmol; 2022 May; 100(3):e807-e812. PubMed ID: 34289237
[TBL] [Abstract][Full Text] [Related]
12. Correlation between spectral-domain optical coherence tomography findings and visual outcome after primary rhegmatogenous retinal detachment repair.
Gharbiya M; Grandinetti F; Scavella V; Cecere M; Esposito M; Segnalini A; Gabrieli CB
Retina; 2012 Jan; 32(1):43-53. PubMed ID: 21778929
[TBL] [Abstract][Full Text] [Related]
13. Restoration of foveal thickness and architecture after macula-off retinal detachment repair.
dell'Omo R; Viggiano D; Giorgio D; Filippelli M; Di Iorio R; Calo' R; Cardone M; Rinaldi M; dell'Omo E; Costagliola C
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1040-50. PubMed ID: 25613940
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic
Kiraly P; Cottriall CL; Taylor LJ; Jolly JK; Cehajic-Kapetanovic J; Yusuf IH; Martinez-Fernandez de la Camara C; Shanks M; Downes SM; MacLaren RE; Fischer MD
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892166
[TBL] [Abstract][Full Text] [Related]
15. Outer Retinal Alterations Associated With Visual Outcomes in Best Vitelliform Macular Dystrophy.
Augstburger E; Orès R; Mohand-Said S; Mrejen S; Keilani C; Antonio A; Condroyer C; Andrieu C; Sahel JA; Zeitz C; Audo I
Am J Ophthalmol; 2019 Dec; 208():429-437. PubMed ID: 31465755
[TBL] [Abstract][Full Text] [Related]
16. Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis.
Deng C; Zhao PY; Branham K; Schlegel D; Fahim AT; Jayasundera TK; Khan N; Besirli CG
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1543-1550. PubMed ID: 35001204
[TBL] [Abstract][Full Text] [Related]
17. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.
Matsumoto H; Sato T; Kishi S
Am J Ophthalmol; 2009 Jul; 148(1):105-10.e1. PubMed ID: 19327740
[TBL] [Abstract][Full Text] [Related]
18. Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy.
Maruko I; Iida T; Sekiryu T; Saito M
Am J Ophthalmol; 2009 Mar; 147(3):489-494.e1. PubMed ID: 19058780
[TBL] [Abstract][Full Text] [Related]
19. Analysis of spectral-domain optical coherence tomography in preterm children: retinal layer thickness and choroidal thickness profiles.
Park KA; Oh SY
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7201-7. PubMed ID: 23033393
[TBL] [Abstract][Full Text] [Related]
20. Contrast sensitivity and foveal microstructure following vitrectomy for epiretinal membrane.
Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
Invest Ophthalmol Vis Sci; 2014 Nov; 55(11):7594-600. PubMed ID: 25370511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
